TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer.

Antonio Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.